| FDA | Food and Drug Administration |
| IgE | Immunoglobulin E |
| nsLTP | non-specific lipid transfer protein |
| PR-10 | Pathogen-related protein 10 |
| nsLTP2 | non-specific lipid transfer protein type 2 |
| PCR | Polymerase Chain Reaction |
| WB | Western blot |
| ELISA | enzyme-linked immunosorbent assay |
| MS | Mass spectrometry |
| LC-MS/MS | liquid chromatography–tandem mass spectrometry |
| IgG | Immunoglobulin G |
| UHP | Ultra-high pressure |
| HTHP | High-temperature, high-pressure |
| AGEs | advanced glycation end products |
| BBL | bayberry leaf |
| CA | chlorogenic acid |
| DIC | instant controlled pressure-drop |
| ED | eliciting dose |
| EGCG | epigallocatechin gallate |
| LOD | limit of detection |
| LOQ | limit of quantification |
| SDS-PAGE | sodium dodecyl sulfate–polyacrylamide gel electrophoresis |
| TM | tropomyosin |
| β-LG | β-lactoglobulin |